[Asia Economy Reporter Song Seung-yoon] Remed announced on the 28th that it will acquire 2 million shares of its remote treatment business subsidiary Remed Nexcare for 1 billion KRW.


After acquiring the shares, Remed's stake in Remed Nexcare will be 100%. The scheduled date for the share acquisition is the 18th of next month.



Remed stated that the purpose of acquiring the shares is "the establishment of a corporation and investment for entering the remote treatment business."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing